Literature DB >> 17098020

Agonal period in potential non-heart-beating donors.

S Sohrabi1, A Navarro, J Asher, C Wilson, A Sanni, H Wyrley-Birch, V Anand, M Reddy, D Rix, B Jacques, D Manas, D Talbot.   

Abstract

The shortage of donor kidneys for renal transplantation is becoming more severe as the gap between the number of patients waiting for renal transplantation and the number of cadaveric organs available continues to widen. Therefore, many centres have started using non-heart-beating (NHB) donors. There was no clear plan for maximal duration of agonal period in Maastricht category NHB donors after withdrawal of treatment in Newcastle. This withdrawal has been audited in retrospect. Our current wait time is now a maximum of 5 hours; however, previously there have been some considerably longer periods. Concern has always been expressed about poor quality with protracted periods. Nonuse in this review of 58 kidneys can be expressed against time: 0 to 2 hours 13%, 2 to 5 hours 33%, and >5 hours 45%. Therefore, though the nonuse rate was significantly different between 0 to 2 hours and >5 hours (P < .05, chi-square), there were 16 transplants performed with kidneys >2 hours and 12 transplanted >5 hours. In conclusion, although good usable kidneys can still be used with protracted withdrawal, there are considerable logistical difficulties with our 5-hour cut-off, which means that one third of potential kidneys will not be utilized.

Entities:  

Mesh:

Year:  2006        PMID: 17098020     DOI: 10.1016/j.transproceed.2006.08.005

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  Kidney donation after cardiac death.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-06-06

2.  Transplantation: Prolonged agonal time--not a contraindication for transplantation.

Authors:  L W Ernest van Heurn
Journal:  Nat Rev Nephrol       Date:  2011-06-21       Impact factor: 28.314

Review 3.  Kidney donation after circulatory death (DCD): state of the art.

Authors:  Dominic M Summers; Christopher J E Watson; Gavin J Pettigrew; Rachel J Johnson; David Collett; James M Neuberger; J Andrew Bradley
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.